140
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Accuracy of a blood glucose monitoring system that recognizes insufficient sample blood volume and allows application of more blood to the same test strip

&
Pages 75-82 | Received 29 Aug 2019, Accepted 10 Dec 2019, Published online: 10 Jan 2020

References

  • Gao L, Ji L, Su Q, et al. Impact of structured self-monitoring of blood glucose on the quality of life of insulin-treated Chinese patients with type 2 diabetes mellitus: results from the COMPASS study. Diabetes Res Clin Pract. 2016;112:88–93.
  • Kato N, Cui J, Kato M. Structured self-monitoring of blood glucose reduces glycated hemoglobin in insulin-treated diabetes. J Diabetes Investig. 2013;4(5):450–453.
  • Nishimura A, Harashima SI, Fujita Y, et al. Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial. J Diabetes Complications. 2017;31(1):228–233.
  • American Diabetes Association. Standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl):1.
  • United States Food and Drug Administration. Self-monitoring blood glucose test systems for over-the-counter use - draft guidance for industry and food and drug administration staff. 2018. [cited 2018 Nov 30]. Available from: https://www.federalregister.gov/documents/2018/11/30/2018-26028/self-monitoring-blood-glucose-test-systems-for-over-the-counter-use-draft-guidance-for-industry-and
  • Izahar S, Lean QY, Hameed MA, et al. Content analysis of mobile health applications on diabetes mellitus. Front Endocrinol. 2017;8:318.
  • Hou C, Carter B, Hewitt J, et al. Do mobile phone applications improve glycemic control (hba1c) in the self-management of diabetes? A systematic review, meta analysis, and grade of 14 randomized trials. Diabetes Care. 2016;39(11):2089–2095.
  • Mannucci E, Antenore A, Giorgino F, et al. Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: a meta-analysis of randomized controlled trials. J Diabetes Sci Technol. 2018;12(1):183–189.
  • Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2009;3(4):903–913.
  • Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009;3(4):971–980.
  • Pfützner A, Schipper C, Ramljak S, et al. Evaluation of the effects of insufficient blood volume samples on the performance of blood glucose self-test meters. J Diabetes Sci Technol. 2013;7(6):1522–1529.
  • Freckmann G, Jendrike N, Baumstark A, et al. User performance evaluation of four blood glucose monitoring systems applying ISO 15197:2013 accuracy criteria and calculation of insulin dosing errors. Diabetes Ther. 2018;9(2):683–697.
  • Christiansen M, Greene C, Pardo S, et al. a new, wireless-enabled blood glucose monitoring system that links to a smart mobile device: accuracy and user performance evaluation. J Diabetes Sci Technol. 2017;11(3):567–573.
  • International Organization for Standardization. ISO 15197:2013. In vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland: International Organization for Standardization; 2013. Available from: https://www.iso.org/standard/54976.html
  • US National Institute of Health (NIH) website. Checklist for evaluating whether a clinical trial or study is an applicable clinical trial (ACT) under 42 CFR 11.22(b) for clinical trials initiated on or after january 18, 2017. 2018; [cited 2019 Jul 15]. Available from: https://prsinfo.clinicaltrials.gov/ACT_Checklist.pdf
  • International Organization for Standardization. ISO 17511:2003. In vitro diagnostic medical devices – measurement of quantities in biological samples – metrological traceability of values assigned to calibrators and control materials. Geneva, Switzerland: International Organization for Standardization; 2003. Available from: https://www.iso.org/standard/30716.html
  • Parkes JL, Slatin SL, Pardo S, et al. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23(8):1143–1148.
  • Pardo S, Dunne N, Simmons DA. Using radar plots to demonstrate the accuracy and precision of 6 blood glucose monitoring systems. J Diabetes Sci Technol. 2017;11(5):966–969.
  • Pardo S, Dunne N, Simmons DA. Use of radar plots to compare the analytical performance of five blood glucose monitoring systems. Ther Deliv. 2019 Nov 1. Epub ahead of print. DOI:10.4155/tde-2019-0046.
  • Duran A, Martin P, Runkle I, et al. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: the St carlos study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes. 2010;2(3):203–211.
  • Polonsky WH, Fisher L, Schikman CH, et al. A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study. Diabetes Technol Ther. 2011;13(8):797–802.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.